CHIC: Coalition to Strengthen the HPV Immunization Community – Briefing on HPV and Vaccination

This CHIC briefing document provides a concise overview of HPV disease burden, vaccination programmes, and key challenges facing low- and middle-income countries. It describes HPV as the most common sexually transmitted infection globally, responsible for over 630,000 new cancer cases and 311,000 deaths annually, with 530,000 being cervical cancers. The brief highlights that over 85% […]

Status of HPV disease and vaccination programmes in LMICs: Introduction to special issue

In this introduction to the special issue, Borda and colleagues present an overview of the current global epidemiology of cervical cancer incidence and mortality, with the highest burden concentrated in Africa and Asia. The article highlights decreased HPV vaccination coverage in recent years and underlines the need for new vaccine introductions and programme strengthening to […]

Mises à jour sur l’élimination du cancer du col de l’utérus et le paysage de la vaccination contre le HPV: séance de questions-réponses

Emily Kobayashi (Responsable du programme PVH, Gavi) et des responsables du PEV (Guinée, Malawi, Cameroun, RDC) ont discuté de la mise en œuvre du modèle Gavi 6.0 lors du Symposium CHIC 2025. La session a précisé que la nouvelle subvention unifiée intègre les ressources de Gavi aux budgets nationaux et aux financements partenaires (ex. Banque […]

Chiffres actuels : prévalence et incidence des maladies liées au HPV dans la région AFRO

Le Dr Safdar Nosheen (OMS AFRO) a présenté des données épidémiologiques au Symposium CHIC 2025, soulignant que l’Afrique supporte un fardeau disproportionné de maladies liées au PVH, regroupant 18 des 20 pays les plus touchés au monde. En Afrique subsaharienne, le cancer du col de l’utérus représente environ 30 % des diagnostics de cancer chez […]

Updates in Cervical Cancer Elimination and HPV Vaccination Landscape: Q&A Session

Emily Kobayashi (Head of HPV Program, Gavi) and regional EPI managers (Guinea, Malawi, Cameroon, DRC) addressed the operationalization of the Gavi 6.0 model at the 2025 CHIC Symposium. The session clarified that the new unified grant integrates Gavi resources with national budgets and partner funding (e.g., World Bank). Key concerns focused on the 4% co-financing […]

Current Numbers: HPV disease prevalence and incidence across the AFRO region

Dr. Safdar Nosheen (WHO AFRO) presented critical epidemiological data at the 2025 CHIC Symposium, emphasizing that Africa bears a disproportionate burden of HPV-related diseases, with 18 of the 20 highest-burden countries globally located in the region. In sub-Saharan Africa, cervical cancer accounts for approximately 30% of female cancer diagnoses, with mortality rates reaching 23 per […]

Cervical cancer disease burden in the region/ HPV related cancers incidence and mortality in Africa

Dr. Biey Nsiari Muzeyi Joseph, WHO focal point for vaccination in West Africa, presented an overview of HPV-related cervical cancer incidence, mortality, and socio-economic impact in Africa. He recalled the 2018 WHO call to action and the 2020 global strategy targeting 90-70-90 goals for vaccination, screening, and treatment by 2030. The presentation highlighted Africa’s disproportionate […]

Cervical Cancer Landscape In Sub-Saharan Francophone Africa – Q&A Sessions

During the discussion session, participants raised questions on the shift to single-dose HPV vaccination, particularly experiences from Cameroon and the potential for countries like Mauritania to transition from two to one dose. Concerns were voiced about vaccine supply constraints and the risk of discouraging countries if revitalization efforts are hindered by shortages. Delegates highlighted the […]

>